Skip to main content
. 2019 Oct 10;87(4):664–671. doi: 10.1093/neuros/nyz428

TABLE 1.

Baseline Characteristics

Baseline characteristics All patients (N = 293) n (%) or median (IQR)
Age, years 63 (IQR: 56-68)
Gender
 Male 144 (49%)
 Female 141 (58%)
 Unrecorded 8 (3%)
Time of appearance of brain metastases
 Metachronous 161 (60%)
 Synchronous 106 (40%)
Prior whole-brain irradiation
 No 61 (21%)
 Yes 232 (79%)
Number of metastases >2 cm treated with GKRS
 0 167 (57)
 1 95 (32)
 2 13 (4)
 3 4 (1)
 Unrecorded 14 (5)
Time from WBRT to SRS, days 258 (IQR: 166-431)
Total number of lesions treated with SRS 2 (IQR: 1-5)
Total SRS treatment volume, cc 3.3 (IQR: 0.91-7.60)
Largest brain metastases SRS volume 1.86 (0.50-6.03)
Mean SRS marginal dose, Gy 18.0 (16.0-19.84)